Cambridge researchers have shown how commonly used sweeteners slow the growth of certain gut bacteria. One sweetener in particular—isosteviol—when combined with the antidepressant duloxetine, significantly impaired two important ...
Jul 16, 2026
0
27
A randomized trial conducted by the Alliance for Clinical Trials in Oncology has found that duloxetine, a medication commonly used to treat chronic pain and psychiatric conditions, does not prevent nerve damage caused by ...
Apr 11, 2026
0
7
Fibromyalgia is a long-term chronic condition that causes widespread pain in the muscles and soft tissues throughout the body. The illness can affect people of all ages and has a major impact on quality of life, often making ...
Incident use of gabapentin is not associated with an increase in fall-related hospital visits compared with duloxetine use, according to a study published online Jan. 7 in the Annals of Internal Medicine.
Jan 7, 2025
0
27
University of Sydney research has found people over 65 are being prescribed antidepressants as pain treatment based on international guidelines that use limited evidence. The paper is published in the British Journal of Clinical ...
Sep 13, 2024
0
44
Karolinska Institutet has discovered that an already registered antidepressant, duloxetine, may also have positive effects on memory and cognitive functions in the elderly.
Aug 29, 2024
0
68
An investigational medication designated TAS-303 shows efficacy and safety in treatment of women with stress urinary incontinence (SUI), reports a placebo-controlled clinical trial in the August issue of The Journal of Urology.
Jul 11, 2024
0
33
About 1 in 5 people globally live with chronic pain, and it is a common reason for seeing a doctor, accounting for one in five GP appointments in the UK.
May 22, 2024
0
35
Most antidepressants used for chronic pain are being prescribed with "insufficient" evidence of their effectiveness, scientists have warned.
May 9, 2023
0
73
Researchers from Emory University are continuing to gain a deeper understanding of factors that help predict how well three first-line treatments work for adults diagnosed with major depressive disorder (MDD).
Apr 6, 2023
0
64
